Fundraising Fox
Ena Respiratory
Melbourne, AU · Founded 2020 · 9 employees on LinkedIn · 3 known investors
Find your way into Ena Respiratory
137 people in our graph share verified history with the Ena Respiratory team — schools, employers, funds. One of them is your warm intro.
John Kurekunlockedknows Christophe Demaison · together at Ena Respiratory (overlapped)
×3knows the team · via Cancer Research Technology Ltd, London - UK
×2knows the team · via Institut Pasteur, Paris - France
×6knows the team · via Institute of Child Health, UCL. London, UK
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.
Founders & leadership
CD
Christophe DemaisonCEOChristophe Demaison is CEO of Ena Respiratory, which develops and brings respiratory treatments through regulatory approval and to market in the US and other regions. He has experience in life sciences ventures, capital raising, and strategic partnerships in pharmaceutical and biotech sectors.
Investors · 3
Frequently asked questions
- What does Ena Respiratory do?
- ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.
- Who are Ena Respiratory's investors?
- Ena Respiratory's investors include Brandon BioCatalyst, Stoic VC, UniSeed Pty Ltd..
- Where is Ena Respiratory headquartered?
- Ena Respiratory is headquartered in Melbourne, AU.